The FDA announced today that it authorized marketing for a stimulator device that treats gait deficit in those with multiple sclerosis (MS). Helius Medical’s portable neuromodulation stimulator (PoNS) is a neuromuscular tongue stimulator that uses a non-implantable apparatus to generate electrical pulses for stimulation of the trigeminal and facial nerves via the tongue to treat […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
BrainScope launches next-gen concussion diagnostic device
BrainScope announced that it launched its third FDA-cleared algorithm for concussion diagnosis on the BrainScope device. Bethesda, Md.–based BrainScope’s Concussion Index is the first physiological marker of concussive injury that aids clinicians in the assessment of patients at baseline, point of injury and through recovery, according to a news release. The index adds to BrainScope’s […]
Racial disparities remain despite increased mechanical clot removal in stroke patients
Data presented at the American Stroke Association’s International Stroke Conference 2021 shows that racial disparities persist in stroke treatment. According to a news release, mechanical removal of blood clots causing a stroke is increasing, but there remain racial differences in the treatment, a study shows. Get the full story at our sister site, Medical Design […]
Viz.ai raises $71 million Series C, touts positive data for stroke care outcomes
Artificial intelligence platform developer Viz.ai announced that it raised $71 million in a Series C financing round. San Francisco-based Viz.ai develops AI software for treating acute ischemic stroke. The software uses a computer-aided triage system to identify a suspected large-vessel occlusion via CT scan and alerts a stroke team specialist to reduce the time to […]
MagVenture launches brain stimulation clinical positioning system
MagVenture announced today that it launched the patent-pending MagVenture Flow Arm for brain stimulation positioning. Alpharetta, Ga.–based MagVenture’s Flow Arm clinical positioning system is designed to optimize the delivery of the company’s FDA-cleared protocols for non-invasive brain stimulation technology in treating major depressive disorder and as an adjunct therapy for OCD, according to a news […]
Italfarmaco, Luye enter commercialization pact for transdermal Alzheimer’s treatment
Italfarmaco Group and Luye Pharma announced today that they entered into a commercialization agreement for Rivastigmine MD. Under the agreement, Milan, Italy–based Italfarmco receives exclusive rights to commercialize the Rivastigmine multi-day transdermal patch in four European companies, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
How Bionaut Labs aims to tackle brain tumors with microrobots
The roboticist Michael Shpigelmacher was one of the founders of PrimeSense, a robotic 3-D vision technology company Apple acquired in 2013. PrimeSense created technology empowering the Microsoft Xbox Kinect and the iPhone’s Face ID feature, allowing users to use facial recognition to unlock their phones. Now Shpigelmacher has set his sights on drug-delivery with Bionaut […]
Neurelis closes $114M Series D for diazepam nasal spray
Neurelis announced today that it closed a $114 million Series D financing round to support its lead orphan drug product. San Diego-based Neurelis’ Valtoco (diazepam nasal spray) is a proprietary formulation incorporating the science of Intravail transmucosal absorption enhancement technology. The drug enables the noninvasive delivery of a range of drugs, while the company focuses on […]
FDA clears once-daily ADHD capsule from Corium
Corium (NSDQ:CORI) announced today that it received FDA approval for its once-daily Azstarys oral capsule for treating ADHD symptoms. Boston-based Corium touts its Azstarys (serdexmethylphenidate [SDX] and dexmethylphenidate [d-MPH]) drug as the first and only product containing a d-MPH oral prodrug for treating ADHD (attention deficit hyperactivity disorder) symptoms in patients aged six years and older, […]
FDA grants breakthrough nod to Anuncia’s cerebral spinal fluid treatment
Anuncia announced today that it received FDA breakthrough device designation for its ReFlow system for cerebral spinal fluid (CSF) management. Lowell, Mass.-based Anuncia’s ReFlow Mini is intended to treat CSF disorders requiring shunting, including hydrocephalus, according to a news release. It has been optimized to serve a broad hydrocephalus population, including infants with non-communicating hydrocephalus, […]
Axonics, Micro Systems Technologies partners to make rechargeable SNM device
Axonics (NSDQ:AXNX) announced today that it entered into a strategic alliance with Micro Systems Technologies. Micro Systems Technologies (MST) manufactures printed circuit board assemblies for the Axonics r-SNM (sacral neuromodulation) system in Lake Oswego, Oregon, according to a news release. The newly minted strategic alliance expands the relationship between the two as the companies collaborate […]